Skip to content

Meet Danielle

Danielle's story

HRT Access Fund recipient

Danielle

Danielle (she/her) is a 23-year-old trans women who is currently unemployed and struggling to make ends meet. In the future, she hopes to access facial feminization surgery; for now, she is relieved to have her HRT access covered and allow her to focus on employment without feeling discomfort in the workplace. She shared, "I will be able to take care of all my daily activities without having extreme anxiety attacks due to not feeling comfortable with myself while not on HRT."

Danielle's timeline

  • Award Granted

    July 22, 2022

    Danielle was awarded a grant toward HRT/GaHT!
  • HRT Onboarding Date

    September 12, 2022

    Danielle was seen by her HRT/GaHT provider.

Grant details

$2,200 towards gender-affirming care.

TikTok-a-Thon grantee





About Estrogen+

On average, it costs $1,700+/year for Danielle's care.

What is it?

Estrogen+ refers to the gender-affirming hormone replacement therapy (HRT) methods that some trans women, trans femme, and non-binary people take that result in physical changes which align with their gender identity. Every person's preferences and personal healthcare needs vary, so this can include oral medications, injections, and transdermal patches.

How accessible is it for trans folks to receive this care?

For trans folks who live in states most impacted by anti-trans healthcare legislation, it can be extremely difficult to find a knowledgeable, trans-affirming provider as well as access prescription medication. Many insurance plans do not cover HRT. For trans folks without insurance coverage, the ongoing out-of-pocket expense can be challenging.

What is the impact of this care on the recipient’s life?

Estogen+ introduces a wide range of feminizing physical, emotional, and psychological changes that align with their gender identity. This often leads to a more positive emotional well-being, increased confidence, increased safety when in public, and better opportunities at employment and more.